Genocea Gets $2.7M for Malaria Vaccine

Genocea Biosciences, the Cambridge, MA-based developer of vaccines, said today it has been granted $2.7 million to work on discovering a new malaria vaccine. The grant is from the U.S. Army Medical Research and Materiel Command as part of a research collaboration with the Naval Medical Research Center. Genocea will use its technology to find target antigens for a vaccine, while the Naval Medical Research Center will contribute their expertise in developing sub-unit vaccine formulations.

Trending on Xconomy